(SeeNews) - Nov 8, 2011 -US biofuel and biotechnology firm Solazyme (NASDAQ:SZYM) yesterday posted a net loss of USD 14.1 million (EUR 10.3m) for the third quarter, expanding it from USD 9 million a year ago due to increased expenses.